These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 28616250)

  • 1. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.
    Campion CG; Sanchez-Ferras O; Batchu SN
    Can J Kidney Health Dis; 2017; 4():2054358117705371. PubMed ID: 28616250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
    Luo Y; Zhang W; Qin G
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy: traditional to proteomic markers.
    Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
    Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
    Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
    J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
    Peng L; Chen Y; Shi S; Wen H
    Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
    Quan KY; Yap CG; Jahan NK; Pillai N
    Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
    Lee SY; Choi ME
    Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of diabetic nephropathy, the present and the future.
    Jim B; Santos J; Spath F; Cijiang He J
    Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
    Darmayanti S; Lesmana R; Meiliana A; Abdulah R
    Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
    Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
    J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
    Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
    J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of novel biomarkers in predicting diabetic nephropathy: a review.
    Uwaezuoke SN
    Int J Nephrol Renovasc Dis; 2017; 10():221-231. PubMed ID: 28860837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer.
    Tsai YC; Kuo MC; Hung WW; Wu PH; Chang WA; Wu LY; Lee SC; Hsu YL
    Cell Commun Signal; 2023 Jan; 21(1):10. PubMed ID: 36639674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
    Mu X; Yang M; Ling P; Wu A; Zhou H; Jiang J
    Diabetes Metab Syndr Obes; 2022; 15():247-256. PubMed ID: 35125878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases.
    Wang G; Ouyang J; Li S; Wang H; Lian B; Liu Z; Xie L
    J Transl Med; 2019 Aug; 17(1):264. PubMed ID: 31409386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated Urinary Extracellular Vesicle Small RNAs in Diabetic Nephropathy: Implications for Diagnosis and Therapy.
    Ali H; Malik MZ; Abu-Farha M; Abubaker J; Cherian P; Al-Khairi I; Nizam R; Jacob S; Bahbahani Y; Al Attar A; Thanaraj TA; Al-Mulla F
    J Endocr Soc; 2024 Jul; 8(8):bvae114. PubMed ID: 38966710
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.